Alnylam Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.92 | $120.37 M | -1.65 | 384 | $87.37 M |
APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
BMRN
BioMarin Pharmaceutical Inc. |
$67.07 | $15.32 B | 76.12 | 3040 | $2.85 B |
BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
EXEL
Exelixis, Inc. |
$33.20 | $6.37 B | 33.66 | 1147 | $2.17 B |
HALO
Halozyme Therapeutics, Inc. |
$50.51 | $6.47 B | 21.1 | 350 | $1.02 B |
INCY
Incyte Corporation |
$71.91 | $13.30 B | 17.93 | 2617 | $4.24 B |
ISEE
IVERIC bio, Inc. |
$39.95 | $5.51 B | -22.44 | 163 | $0 |
KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
KRYS
Krystal Biotech, Inc. |
$155.81 | $4.70 B | 75.42 | 275 | $290.52 M |
MDGL
Madrigal Pharmaceuticals, Inc. |
$320.81 | $5.21 B | -10.55 | 528 | $180.13 M |
PRQR
ProQR Therapeutics N.V. |
$2.62 | $151.08 M | -5.14 | 156 | $6.51 M |
RARE
Ultragenyx Pharmaceutical Inc. |
$42.66 | $3.44 B | -5.21 | 1294 | $560.23 M |
RETA
Reata Pharmaceuticals, Inc. |
$172.36 | $6.57 B | -66.29 | 321 | $2.22 M |
SGEN
Seagen Inc. |
$228.74 | $43.15 B | -57.19 | 3256 | $1.96 B |
UTHR
United Therapeutics Corporation |
$355.39 | $12.20 B | 13.02 | 1305 | $2.88 B |
WVE
Wave Life Sciences Ltd. |
$13.03 | $711.49 M | -11.39 | 287 | $108.30 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
